scholarly journals P-A3-10 Ice-binding mechanism of the antifreeze protein by MD simulations

1996 ◽  
Vol 65 ◽  
pp. 42
Nature ◽  
1995 ◽  
Vol 375 (6530) ◽  
pp. 427-431 ◽  
Author(s):  
F. Sicheri ◽  
D. S. C. Yang

2018 ◽  
Vol 42 (3) ◽  
pp. e12506 ◽  
Author(s):  
Cong Thanh Nguyen ◽  
Min Yuan ◽  
Jing Song Yu ◽  
Tai Ye ◽  
Hui Cao ◽  
...  

2015 ◽  
Vol 6 (7) ◽  
pp. 1162-1167 ◽  
Author(s):  
Konrad Meister ◽  
Stephan Lotze ◽  
Luuk L. C. Olijve ◽  
Arthur L. DeVries ◽  
John G. Duman ◽  
...  

2012 ◽  
Vol 416 (5) ◽  
pp. 713-724 ◽  
Author(s):  
Adam J. Middleton ◽  
Christopher B. Marshall ◽  
Frédérick Faucher ◽  
Maya Bar-Dolev ◽  
Ido Braslavsky ◽  
...  

2002 ◽  
Vol 83 (4) ◽  
pp. 2202-2210 ◽  
Author(s):  
Yuhua Cheng ◽  
Zuoyin Yang ◽  
Hongwei Tan ◽  
Ruozhuang Liu ◽  
Guangju Chen ◽  
...  

2016 ◽  
Vol 473 (21) ◽  
pp. 4011-4026 ◽  
Author(s):  
Jing Cheng ◽  
Yuichi Hanada ◽  
Ai Miura ◽  
Sakae Tsuda ◽  
Hidemasa Kondo

Snow mold fungus, Typhula ishikariensis, secretes seven antifreeze protein isoforms (denoted TisAFPs) that assist in the survival of the mold under snow cover. Here, the X-ray crystal structure of a hyperactive isoform, TisAFP8, at 1.0 Å resolution is presented. TisAFP8 folds into a right-handed β-helix accompanied with a long α-helix insertion. TisAFP8 exhibited significantly high antifreeze activity that is comparable with other hyperactive AFPs, despite its close structural and sequence similarity with the moderately active isoform TisAFP6. A series of mutations introduced into the putative ice-binding sites (IBSs) in the β-sheet and adjacent loop region reduced antifreeze activity. A double-mutant A20T/A212S, which comprises a hydrophobic patch between the β-sheet and loop region, caused the greatest depression of antifreeze activity of 75%, when compared with that of the wild-type protein. This shows that the loop region is involved in ice binding and hydrophobic residues play crucial functional roles. Additionally, bound waters around the β-sheet and loop region IBSs were organized into an ice-like network and can be divided into two groups that appear to mediate separately TisAFP and ice. The docking model of TisAFP8 with the basal plane via its loop region IBS reveals a better shape complementarity than that of TisAFP6. In conclusion, we present new insights into the ice-binding mechanism of TisAFP8 by showing that a higher hydrophobicity and better shape complementarity of its IBSs, especially the loop region, may render TisAFP8 hyperactive to ice binding.


2020 ◽  
Author(s):  
Ancy Iruthayaraj ◽  
Sivanandam Magudeeswaran ◽  
Kumaradhas Poomani

<p>Initially, the SARS-CoV-2 virus was emerged from Wuhan, China and rapidly spreading across the world and urges the scientific community to develop antiviral therapeutic agents. Among several strategies, drug repurposing will help to react immediately to overcome COVID-19 pandemic. In the present study, we have chosen two clinical trial drugs TMB607 and TMC310911 are the inhibitors of HIV-1 protease to use as the inhibitors of SARS-CoV-2 main protease (M<sup>pro</sup>) enzyme. To make use of these two inhibitors as the repurposed drugs for COVID-19, it is essential to know the molecular basis of binding mechanism of these two molecules with the SARS-CoV-2 main protease (M<sup>pro</sup>). Understand the binding mechanism; we performed the molecular docking, molecular dynamics (MD) simulations and binding free energy calculations against the SARS-CoV-2 M<sup>pro</sup>. The docking results indicate that both molecules form intermolecular interactions with the active site amino acids of M<sup>pro</sup> enzyme. However, during the MD simulations, TMB607 forms strong interactions with the key amino acids of M<sup>pro</sup> and remains intact. The RMSD and RMSF values of both complexes were stable throughout the MD simulations. The MM-GBSA binding free energy values of both complexes are -43.7 and -34.9 kcal/mol, respectively. This <i>in silico</i> study proves that the TMB607 molecule binds strongly with the SARS-CoV-2 M<sup>pro</sup> enzyme and it is suitable for the drug repurposing of COVID-19 and further drug designing.</p>


Biochemistry ◽  
1998 ◽  
Vol 37 (51) ◽  
pp. 17745-17753 ◽  
Author(s):  
Michèle C. Loewen ◽  
Wolfram Gronwald ◽  
Frank D. Sönnichsen ◽  
Brian D. Sykes ◽  
Peter L. Davies

2007 ◽  
Vol 55 (19) ◽  
pp. 7654-7658 ◽  
Author(s):  
Chao Zhang ◽  
Hui Zhang ◽  
Li Wang ◽  
Junhui Zhang ◽  
Huiyuan Yao

Sign in / Sign up

Export Citation Format

Share Document